1999Chinese Journal of DermatologyRequires access

Growth inhibition of Candida albicans by interleukin-2 activated human peripheral blood mononuclear cells

Wengang Li, Yingling Chen, Liyi Zhou

Open publisher page 0 citations

Abstract

Objective To investgate the ability of cytokine activated human peripheral blood mononuclear cell (PMBC) in inhibiting Candida albicans in vitro Methods PBMCs of thirty six volunteers were obtained by Ficoll Hypaque density centrifugation and cultured for 7 days in cell wells During the culture period different cytokines including, recombinant human tumor necrosis factor (TNF), interleukin 1(IL 1), gamma interferon(IFN γ) and interleukin 2(IL 2) were added respectively Then, the treated PBMCs were incubated with C albicans in vitro for 2h to determine the number of colony forming unit of C albicans per milliliter(cfu/mL) Results Compared to that of controls,there was a significant decrease of C albicans cfu/mL in IL 2 activated group (P 0 01) Whereas, no inhibitory effect was observed in IL 1,IFNγor TNFαstimulated groups The inhibitory effect of IL 2 activated PBMC was related to the concentration of IL 2 and the duration of culture PBMC was not able to inhibit C albicans growth directly(P 0 05) IL 2 itself failed to inhibit the growth of C albicans Conclusion These data demonstrate that IL 2 is capable of stimulating antifungal activity of PBMC which may play an important role in host defensing against C albicans infections and provide a new approach for the treatment

About this research paper

What this paper is about

Objective To investgate the ability of cytokine activated human peripheral blood mononuclear cell (PMBC) in inhibiting Candida albicans in vitro Methods PBMCs of thirty six volunteers were obtained by Ficoll Hypaque density centrifugation and cultured for 7 days in cell wells During the culture period different cytokines including, recombinant human tumor necrosis factor (TNF), interleukin 1(IL 1), gamma interferon(IFN γ) and interleukin 2(IL 2) were added respectively Then, the treated PBMCs were incubated with C albicans in vitro for 2h to determine the number of colony forming unit of C albicans per milliliter(cfu/mL) Results Compared to that of controls,there was a significant decrease of C albicans cfu/mL in IL 2 activated group (P 0 01) Whereas, no inhibitory effect was observed in IL 1,IFNγor TNFαstimulated groups The inhibitory effect of IL 2 activated PBMC was related to the concentration of IL 2 and the duration of culture PBMC was not able to inhibit C albicans growth directly(P 0 05) IL 2 itself failed to inhibit the growth of C albicans Conclusion These data demonstrate that IL 2 is capable of stimulating antifungal activity of PBMC which may play an important role in host defensing against C albicans infections and provide a new approach for the treatment

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investgate the ability of cytokine activated human peripheral blood mononuclear cell (PMBC) in inhibiting Candida albicans in vitro Methods PBMCs of thirty six volunteers were obtained by Ficoll Hypaque density centrifugation and cultured for 7 days in cell wells During the culture period different cytokines including, recombinant human tumor necrosis factor (TNF), interleukin 1(IL 1), gamma interferon(IFN γ) and interleukin 2(IL 2) were added respectively Then, the treated PBMCs were incubated with C albicans in vitro for 2h to determine the number of colony forming unit of C albicans per milliliter(cfu/mL) Results Compared to that of controls,there was a significant decrease of C albicans cfu/mL in IL 2 activated group (P 0 01) Whereas, no inhibitory effect was observed in IL 1,IFNγor TNFαstimulated groups The inhibitory effect of IL 2 activated PBMC was related to the concentration of IL 2 and the duration of culture PBMC was not able to inhibit C albicans growth directly(P 0 05) IL 2 itself failed to inhibit the growth of C albicans Conclusion These data demonstrate that IL 2 is capable of stimulating antifungal activity of PBMC which may play an important role in host defensing against C albicans infections and provide a new approach for the treatment

Key concepts: Peripheral blood mononuclear cell, Candida albicans, Corpus albicans, Cytokine, Microbiology, Tumor necrosis factor alpha, Interleukin, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
Growth inhibition of Candida albicans by interleukin-2 activated human peripheral blood mononuclear cells — Research Paper | ScholarLens